These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2017598)

  • 21. [Asymmetric septal hypertrophy of sporadic form with abnormal thallium perfusion and myocardial enzymes].
    Nagata S; Minamikawa T; Park YD; Nishimura T; Yutani C; Ohmori F; Sakakibara H; Nimura Y
    J Cardiogr Suppl; 1986; (9):57-65. PubMed ID: 3760618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of dipyridamole Tl-201 emission computed tomography perfusion abnormality for evaluating pathophysiological and pathological aspects in hypertrophic cardiomyopathy.
    Mori T; Yamabe H; Yokota Y; Fukuzaki H
    Jpn Circ J; 1988 Feb; 52(2):111-8. PubMed ID: 3258928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy.
    Pitcher D; Wainwright R; Maisey M; Curry P; Sowton E
    Br Heart J; 1980 Dec; 44(6):650-6. PubMed ID: 7193039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Washout rate in hypertrophic cardiomyopathy assessed by exercise myocardial scintigraphy].
    Genda A; Igarashi Y; Mizuno S; Sugihara N; Kita Y; Suematsu T; Shimizu M; Takeda R; Bunko H; Hisada K
    J Cardiogr; 1986 Dec; 16(4):893-905. PubMed ID: 3429906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging.
    Sakuma H; Takeda K; Tagami T; Nakagawa T; Okamoto S; Konishi T; Nakano T
    Am Heart J; 1993 May; 125(5 Pt 1):1323-8. PubMed ID: 8480584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isotopic study of myocardial perfusion and innervation in 28 patients with primary hypertrophic cardiomyopathy: relation to ventricular arrhythmia].
    Casset-Senon D; Philippe L; Cosnay P; Lopez-Moutault J; Turot-Bracq V; Fauchier JP; Pottier JM
    Arch Mal Coeur Vaiss; 1994 Apr; 87(4):475-83. PubMed ID: 7848036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Minimal redistribution of thallium-201 representing reversible ischemia after coronary bypass surgery: value of quantitative analysis of exercise thallium-201 SPECT].
    Ohtani H; Tamaki N; Mohiuddin IH; Yonekura Y; Konishi J; Hirata K; Ban T
    J Cardiol; 1991; 21(4):835-46. PubMed ID: 1844439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of diltiazem on myocardial perfusion abnormalities during exercise in patients with hypertrophic cardiomyopathy.
    Sugihara H; Taniguchi Y; Ito K; Terada K; Matsumoto K; Kinoshita N; Azuma A; Ushijima Y; Maeda T; Nakagawa M
    Ann Nucl Med; 1998 Dec; 12(6):349-54. PubMed ID: 9972372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of transient dilation of the left ventricular cavity in patients with hypertrophic cardiomyopathy by exercise thallium-201 scintigraphy].
    Sugihara H; Shiga K; Umamoto I; Harada Y; Katahira T; Nakagawa T; Matsubara K; Nakamura T; Terashima S; Azuma A
    Kaku Igaku; 1990 Nov; 27(11):1281-9. PubMed ID: 2290196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidental detection of apical hypertrophic cardiomyopathy by myocardial perfusion imaging.
    Irwin RB; Arumugam P; Khattar RS
    Nucl Med Commun; 2010 Apr; 31(4):286-93. PubMed ID: 20087240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy.
    Udelson JE; Bonow RO; O'Gara PT; Maron BJ; Van Lingen A; Bacharach SL; Epstein SE
    Circulation; 1989 May; 79(5):1052-60. PubMed ID: 2785441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apical hypertrophy caused by glycogen storage disease creating artifacts in myocardial perfusion imaging.
    Shi H; Cotton J; Starsiak MD; Galt JR; Halkar RK
    Clin Nucl Med; 2006 Apr; 31(4):229-31. PubMed ID: 16550025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ischemic myocardial injury evaluated using positron emission tomography in children with coronary artery disease: comparison with thallium-201 SPECT].
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Yonekura Y; Yamashita K; Konishi J; Ban T; Mikawa H
    J Cardiol; 1992; 22(1):21-6. PubMed ID: 1307567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic effects of oral dipyridamole on myocardial perfusion and left ventricular function in patients with hypertrophic cardiomyopathy].
    Kihara K
    Kaku Igaku; 1990 Feb; 27(2):107-15. PubMed ID: 2348579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.
    Dilsizian V; Rocco TP; Freedman NM; Leon MB; Bonow RO
    N Engl J Med; 1990 Jul; 323(3):141-6. PubMed ID: 2362606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy.
    Yoshida N; Ikeda H; Wada T; Matsumoto A; Maki S; Muro A; Shibata A; Imaizumi T
    J Am Coll Cardiol; 1998 Dec; 32(7):1938-42. PubMed ID: 9857875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, psychological and thallium stress studies in patients with chest pain and normal coronary arteries.
    Flugelman MY; Weisstub E; Galun E; Weiss AT; Fischer D; Kaplan De-Nour A; Gotsman MS; Eliakim M
    Int J Cardiol; 1991 Dec; 33(3):401-8. PubMed ID: 1761334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extent and degree of coronary flow reserve in hypertrophic cardiomyopathy assessed by delta Fract map unfolding coronary flow reserve index].
    Kubota Y; Sugihara H; Nakagawa T; Shiga K; Umamoto I; Harada Y; Katahira T; Asayama J; Katsume H; Nakagawa M
    J Cardiol; 1992; 22(1):123-30. PubMed ID: 1307558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Disturbances of myocardial perfusion by exertion scintigraphy in patients with hypertrophic cardiomyopathy and their relationship with sudden death risk factors].
    Chojnowska L; Szumilak B; Piotrowska J; Michalak E; Popławska W; Dabrowski M; Ruzyłło W
    Kardiol Pol; 1991; 35(8):75-82. PubMed ID: 1942760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating levels of heart-type fatty acid-binding protein and its relation to thallium-201 perfusion defects in patients with hypertrophic cardiomyopathy.
    Morioka N; Shigematsu Y; Hamada M; Higaki J
    Am J Cardiol; 2005 Jun; 95(11):1334-7. PubMed ID: 15904639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.